A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Détails bibliographiques
Auteur principal:	Choki, Kinley
Autres auteurs:	Chowdhury, Namara Mariam
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Acute lymphoblastic leukemia Leukemia R/R B-cell precursor ALL FDA Blood cancer Lymphoblastic leukemia. Cancer > Immunotherapy. Monoclonal antibodies > Therapeutic use.
Accès en ligne:	http://hdl.handle.net/10361/24298

Documents similaires

Vision Transformer (ViT) approach in computer aided diagnosis of acute lymphoblastic leukemia
par: Amin, Sifatul, et autres
Publié: (2023)

Identification of childhood leukemia using deep learning
par: Tultul, Farana Naz
Publié: (2018)

Detection of acute Lymphocytic Leukemia (ALL) and its type by image processing and machine learning
par: Chowdhury, Himadri, et autres
Publié: (2019)

Stem cell in cancer disease cure vs cause
par: Chowdhury, Marisha Mansur
Publié: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
par: Khan, Muidul Hasan
Publié: (2024)

Comparative analysis of neural network Models for peripheral blood cell image classification
par: Mollah, Md Tanzid, et autres
Publié: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
par: Fred, Namanda Rogers
Publié: (2021)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
par: Sagar, Baejid Hossain
Publié: (2022)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
par: Tania, Umme
Publié: (2021)

Immunotherapy in the Management of Lung Cancer
par: Tasnim, Humayra
Publié: (2022)

Current practice and approaches of immunotherapy in Cancer treatment
par: Khondokar, Faiza
Publié: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
par: Abir, Shifaty Nur
Publié: (2024)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

The Rainmaker
Publié: (1995)

The rainmaker /
par: Grisham, John
Publié: (1995)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
par: Rahman, Sanjida
Publié: (2024)

CAR-T cell Therapy in B-cell Lymphoma
par: Faruk, Asef
Publié: (2020)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
par: Chowdhury, Mashiat Nawar
Publié: (2018)

Trend in approval of targeted biologics in the last two decades
par: Siddika, Khadiza
Publié: (2024)

Role of toll-like receptors in cancer immunotherapy– a review
par: Khan, Rezia Nowrin
Publié: (2021)

Osteoarthritis: a multi-disciplinary factual review
par: Subah, Nowshin
Publié: (2021)

A study of Osteosarcoma gene profile
par: Arka, Sadib Md.
Publié: (2022)

Study on anticancer drugs approved by the FDA from 2014 to 2023
par: Rattry, Faria Rahman
Publié: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
par: Rahman, Samia
Publié: (2022)

Bioinformatics Analysis Reveals miR-98-5p as a potential Inhibitor of Tumor cell proliferation and metastasis in Colorectal Cancer by targeting the FZD3 receptor of the Wnt signaling pathway
par: Kenneth, Mutebi John
Publié: (2022)

Nanomaterials for diagnosis and treatment of brain cancer
par: Tonny, Tamanna Shahrin
Publié: (2024)

Dendritic cell vaccine for the treatment of cancer
par: Haque, Tanzila
Publié: (2023)

Statistics and informatics in molecular cancer research

S. R Trading Ltd.
par: Swarna, Yasmeen Haque
Publié: (2017)

IEEE R10 technical seminar at BRAC University
par: Rafique, Rumana
Publié: (2015)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
par: Ratu, Tabassum
Publié: (2024)

Post Covid-19 health indications of Covid-19 patients
par: Khan, Tanzim
Publié: (2022)

Recent advancement of biologics in Asthma
par: Evan, Al- Shahriar
Publié: (2022)

Immunotherapy in the treatment of renal cancer
par: Shimu, Sumaya
Publié: (2022)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

Cancer risk factors: a critical review
par: Tabassum, Tahsina
Publié: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
par: Nawar, Anika
Publié: (2019)

Targeting BRAFV600E in the treatment of CRC
par: Roja, Mashwiyat Samrin
Publié: (2024)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
par: Rahman, Towsifur
Publié: (2024)

Role of statins as antagonists of SPARC in gastric cancer
par: Shahmat, Rad
Publié: (2019)